Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types, Secondary cancers
Closed
Phase 1
This trial is for people with a solid tumour that has spread or continued to grow despite treatment (refractory). A solid tumour is any type of cancer apart from those of the blood or lymphatic system such as:
leukaemia
lymphoma
myeloma
Recruitment start: 1 January 2017
Recruitment end: 31 December 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann de Bono
ASTEX Pharmaceuticals
Institute of Cancer Research (ICR)
MSD
The Royal Marsden NHS Foundation Trust
Last reviewed: 6 January 2020
CRUK internal database number: 15517